BlinkLab

The Pharmacology of Human Decision Making Study with Monash University

BlinkLab Limited (ASX:BB1) (“BlinkLab” or the “Company”), an innovative digital healthcare company developing smartphone-based AI powered diagnostic tests for neurological disorders, is pleased to announce a new study to run in partnership with Monash University. The study will evaluate BlinkLab as a medical device able to monitor the therapeutic effects of ketamine on cognitive processes whereby sensory information is converted into decision making. In the future, results from this study can help facilitate cognitive behavioural therapy outcomes in patients with psychiatric conditions such as depression, schizophrenia, epilepsy, and post-traumatic stress disorder (PTSD).


Highlights

  • Study provides a unique opportunity to discover the building blocks of cognition with the potential to transform our understanding of a range of clinical conditions including depression, schizophrenia, epilepsy, PTSD.
  • Potential to demonstrate that drugs targeting glutamatergic neurotransmission can treat some aspects of psychiatric disease symptomology or improve the efficacy of cognitive behavioural therapy.
  • Evaluates ability of BlinkLab tests to be used as a tool to measure pharmacological effects of existing and novel therapeutic agents.

Significance of the Study

Perceptual decision-making is a fundamental cognitive process where sensory information is transformed into meaningful interpretations of the environment, guiding our actions. This field has flourished through the integration of neuroscience and mathematical modelling , providing a robust framework for investigating the neural mechanisms involved. The core idea is that decisions are based on the accumulation of sensory evidence until a decision threshold is reached. These advancements offer a unique opportunity to uncover the fundamental components of cognition and have the potential to revolutionise our understanding of various clinical conditions. By characterising underlying mechanistic abnormalities, refining clinical classifications, and identifying intervention targets, this research holds promise for significant clinical advancements and new therapies for a variety of psychiatric and neurodevelopmental conditions.

The study, conducted by the School of Psychological Sciences at Monash University will investigate the impact of glutamate challenge on perceptual decision making (including behavioural performance, sensorimotor gating) by administering ketamine while participants perform a prepulse inhibition test using BlinkLab application.

The study will be able to demonstrate whether administration of ketamine can disrupt basic sensory encoding mechanisms, which will be detectable in reduced prepulse inhibition.

Study Design

The study will recruit up to 35 healthy adults between 18-55 years old. Each participant will complete 3 testing sessions after ketamine administration. Their participation is expected to take 4-5 weeks per subject.

Terms of the Collaboration Agreement (“Agreement”)

  • Responsibilities: BlinkLab will provide access to its technology, data and shall facilitate the use of its platform during the term of the Agreement.
  • Financial arrangements: None at the date of signing (to be determined via mutual agreement in the future and in a separate agreement).
  • Intellectual Property: Each party will retain all right, title and interest in and to its background intellectual property (copyright, trademarks, designs, know how, patents, plant varieties, confidential information and all other intellectual property as defined in article 2 of the Convention establishing the World Intellectual Property Organization 1967). Any project IP (generated through the study) will be owned by Monash University.
  • Term: Date of signature by the last party to sign (5 August 2024), until completion of the Research Project as communicated by Monash.
  • Termination: Either party may terminate this Agreement by giving between 5 and 20 days written notice (at the terminating party’s election) to the other party if the other party commits a material breach of the Agreement and does not remedy that breach within 10 days after receiving notice requiring them to do so. Monash may terminate this agreement with immediate effect by giving written notice to BlinkLab.
  • Confidentiality: Standard confidentiality terms for an agreement of this nature included.

This announcement has been approved by the Board of Directors.


Click here for the full ASX Release

This article includes content from Blinklab Limited, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.

BB1:AU
The Conversation (0)
Robotic arm assembling chips with NVIDIA logo and "Tech 5" text overlay.

Tech 5: NVIDIA Results Rattle Investors, Trump Signals More Tech Deals to Come

Artificial intelligence (AI) stocks saw continued pressure this week as concerns about overvaluation weighed on the sector ahead of NVIDIA's (NASDAQ:NVDA) results release for its second fiscal quarter.

The company beat Wall Street projections on revenue, earnings and profits, but shares still fell in extended trading on Tuesday (August 26) after it reported no H20 sales to China, where competition from domestic firms is heating up.

John Murillo, chief business officer at B2BROKER, suggested the pullback could present a short-term buying opportunity for high-quality names with strong fundamentals, but cautioned that it could be the start of a broader correction.

Keep reading...Show less
NVIDIA logo.

NVIDIA Delivers Record Quarter as AI Demand Booms, but China Uncertainty Persists

NVIDIA (NASDAQ:NVDA) delivered another blockbuster quarter, reporting record revenue of US$46.7 billion for its second fiscal period as demand for artificial intelligence (AI) infrastructure continues to surge.

The chipmaking giant said sales rose 56 percent from a year earlier and 6 percent from the prior quarter, marking the ninth straight period of year-on-year revenue growth above 50 percent.

Meanwhile, NVIDIA's net income jumped 59 percent to US$26.42 billion from US$16.6 billion. Its adjusted earnings per share were US$1.05, beating analyst forecasts of US$1.01.

Keep reading...Show less
Digital globe with glowing blue patterns and network connections.

ResetData Creates New Public Sovereign AI Supercomputer in Australia

Australian cloud provider ResetData, part of Centuria Capital Group (ASX:CNI), has unveiled AI-F1, a public sovereign artificial intelligence (AI) supercomputer located in Australia.

AI-F1 offers onshore, high-performance AI computing resources for the government, academic and business sectors.

The multi-megawatt supercomputer allows customers to leverage NVIDIA's (NASDAQ:NVDA) NIM microservices, which are designed to work on machine learning and large language models.

Keep reading...Show less
Futuristic 3D microchip with glowing circuits on a blue background.

NVIDIA's Latest AI Chip Comes at Crucial Moment Before Earnings Report

Reports are circulating that NVIDIA (NASDAQ:NVDA) is quietly preparing a new artificial intelligence (AI) chip for China that would surpass the performance of its current H20 model.

The move comes as the US weighs how much access Chinese companies should have to American technology.

Two people briefed on the matter told Reuters that the chip, tentatively called the B30A, is based on NVIDIA's latest Blackwell architecture and is expected to deliver roughly half the computing power of the company’s flagship dual-die B300 accelerator card. Like the H20, the new chip is rumored to include high-bandwidth memory and NVLink interconnect technology, but would offer more power for Chinese clients.

Keep reading...Show less
Two businesspeople shaking hands over financial graphs and "Tech 5" text.

Tech 5: US Government Strikes Big Tech Deal, Perplexity Plots Expansion

Tech stocks led Wall Street to a second consecutive week of gains as a series of data releases reignited optimism about a September interest rate cut from the US Federal Reserve.

A strong consumer price index report was the catalyst, renewing anticipation that the Fed will lower rates when it meets next month. While Thursday's (August 14) less optimistic producer price index report caused a momentary pause, the tech sector's resilience — or defiance — mitigated losses and kept momentum alive.

Here's a look at the key moments that shaped the tech sector this week.

Keep reading...Show less

Latest Press Releases

Related News

×